Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction
Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) or of takotsubo syndrome (TTS). For both diseases, CS is related to a worse long-term outcome. The outcome of CS has not been studied in a direct comparison of patients with MI and patients with TTS. Mortality and cardiova...
Gespeichert in:
| Veröffentlicht in: | Canadian journal of cardiology 2020-06, Vol.36 (6), p.860-867 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 867 |
|---|---|
| container_issue | 6 |
| container_start_page | 860 |
| container_title | Canadian journal of cardiology |
| container_volume | 36 |
| creator | Sattler, Katherine El-Battrawy, Ibrahim Gietzen, Thorsten Kummer, Marvin Lang, Siegfried Zhou, Xiao-bo Behnes, Michael Borggrefe, Martin Akin, Ibrahim |
| description | Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) or of takotsubo syndrome (TTS). For both diseases, CS is related to a worse long-term outcome. The outcome of CS has not been studied in a direct comparison of patients with MI and patients with TTS.
Mortality and cardiovascular complications were compared in patients presenting with CS based on MI or TTS between 2003 and 2017 during a follow-up of 5 years. A total of 138 patients with TTS and 532 patients with MI were included. Of these, 66 patients with MI and 25 patients with TTS developed CS (12% vs 18%, P = 0.08).
Patients with MI and CS had more often malignant arrhythmias (74% vs 28%, P < 0.01), and need for resuscitation (80% vs 24%, P < 0.01) or death (71% vs 24%, P < 0.01) than patients with TTS and CS during the first 30 days. Although the overall rate of death remained higher in MI than in TTS (75.8% vs 52%, log rank, P < 0.01), deaths occurred in TTS constantly throughout the follow-up time, but not in MI. The incidence of heart failure increased in MI but not in TTS (31.8% vs 4%, P < 0.01) during follow-up.
Patients with MI and CS have a worse prognosis than patients with TTS and CS. This is driven by cardiovascular events or death during the first 30 days after the index event. However, patients with TTS and CS show high mortality as well, especially during long-term follow-up.
Le choc cardiogénique (CC) est une complication grave de l’infarctus du myocarde (IM) et du syndrome de Takotsubo (STT). Dans les deux cas, le CC est associé à une issue défavorable à long terme. L’issue du CC n’a jamais fait l’objet d’une comparaison directe entre patients ayant subi un IM et patients ayant subi un STT.
Les auteurs ont comparé la mortalité et les complications cardiovasculaires chez des patients ayant présenté un CC secondaire à un IM ou à un STT entre 2003 et 2017, au cours d’un suivi de 5 ans. Au total, 138 patients ayant subi un STT et 532 patients ayant subi un IM ont été inclus dans l’étude. Parmi eux, 66 patients ayant subi un IM et 25 patients ayant subi un STT ont présenté un CC (12 % vs 18 %, p = 0,08).
Au cours des 30 premiers jours, les patients ayant subi un IM et un CC ont plus souvent présenté des arythmies malignes (74 % vs 28 %, p < 0,01), nécessité une réanimation (80 % vs 24 %, p < 0,01) ou succombé (71 % vs 24 %, p < 0,01) que les patients ayant subi un STT et un CC. Bien que le taux de décès global soit demeuré plus élevé chez les patients ayant subi un |
| doi_str_mv | 10.1016/j.cjca.2019.10.012 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2386434753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X19313467</els_id><sourcerecordid>2386434753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-5ad1d453138198f32112856a548eac215c9902120b99d43a7d2409412fe3789f3</originalsourceid><addsrcrecordid>eNp9kMFOGzEQhi1UBCnwAj1UPvayqcf27tpSL1XUQiQQB4LgZjn2bHDIrlN7Fylvz65Ce-xppJnv_6X5CPkCbA4Mqu_buds6O-cM9LiYM-AnZAYaqqJmdfmJzJjiquCKP5-TzzlvGZNQ19UZORecS80qNSNh2e5TfENP74fexRZpbOjCJh_iBrvg6MNLdK90lcJmg2nE1ge6sq-xz8M60odD59MUWsR2b6fzU-hf6N0huqnC7uiya2xyfYjdJTlt7C7j1ce8II-_f60WN8Xt_fVy8fO2cLyGviitBy9LAUKBVo3gAFyVlS2lQus4lE5rxoGztdZeClt7LpmWwBsUtdKNuCDfjr3jX38GzL1pQ3a429kO45ANF6qSQtalGFF-RF2KOSdszD6F1qaDAWYmxWZrJsVmUjztRsVj6OtH_7Bu0f-L_HU6Aj-OAI5fvgVMJruAnUMfErre-Bj-1_8Ow7uMTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2386434753</pqid></control><display><type>article</type><title>Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sattler, Katherine ; El-Battrawy, Ibrahim ; Gietzen, Thorsten ; Kummer, Marvin ; Lang, Siegfried ; Zhou, Xiao-bo ; Behnes, Michael ; Borggrefe, Martin ; Akin, Ibrahim</creator><creatorcontrib>Sattler, Katherine ; El-Battrawy, Ibrahim ; Gietzen, Thorsten ; Kummer, Marvin ; Lang, Siegfried ; Zhou, Xiao-bo ; Behnes, Michael ; Borggrefe, Martin ; Akin, Ibrahim</creatorcontrib><description><![CDATA[Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) or of takotsubo syndrome (TTS). For both diseases, CS is related to a worse long-term outcome. The outcome of CS has not been studied in a direct comparison of patients with MI and patients with TTS.
Mortality and cardiovascular complications were compared in patients presenting with CS based on MI or TTS between 2003 and 2017 during a follow-up of 5 years. A total of 138 patients with TTS and 532 patients with MI were included. Of these, 66 patients with MI and 25 patients with TTS developed CS (12% vs 18%, P = 0.08).
Patients with MI and CS had more often malignant arrhythmias (74% vs 28%, P < 0.01), and need for resuscitation (80% vs 24%, P < 0.01) or death (71% vs 24%, P < 0.01) than patients with TTS and CS during the first 30 days. Although the overall rate of death remained higher in MI than in TTS (75.8% vs 52%, log rank, P < 0.01), deaths occurred in TTS constantly throughout the follow-up time, but not in MI. The incidence of heart failure increased in MI but not in TTS (31.8% vs 4%, P < 0.01) during follow-up.
Patients with MI and CS have a worse prognosis than patients with TTS and CS. This is driven by cardiovascular events or death during the first 30 days after the index event. However, patients with TTS and CS show high mortality as well, especially during long-term follow-up.
Le choc cardiogénique (CC) est une complication grave de l’infarctus du myocarde (IM) et du syndrome de Takotsubo (STT). Dans les deux cas, le CC est associé à une issue défavorable à long terme. L’issue du CC n’a jamais fait l’objet d’une comparaison directe entre patients ayant subi un IM et patients ayant subi un STT.
Les auteurs ont comparé la mortalité et les complications cardiovasculaires chez des patients ayant présenté un CC secondaire à un IM ou à un STT entre 2003 et 2017, au cours d’un suivi de 5 ans. Au total, 138 patients ayant subi un STT et 532 patients ayant subi un IM ont été inclus dans l’étude. Parmi eux, 66 patients ayant subi un IM et 25 patients ayant subi un STT ont présenté un CC (12 % vs 18 %, p = 0,08).
Au cours des 30 premiers jours, les patients ayant subi un IM et un CC ont plus souvent présenté des arythmies malignes (74 % vs 28 %, p < 0,01), nécessité une réanimation (80 % vs 24 %, p < 0,01) ou succombé (71 % vs 24 %, p < 0,01) que les patients ayant subi un STT et un CC. Bien que le taux de décès global soit demeuré plus élevé chez les patients ayant subi un IM que chez ceux ayant subi un STT (75,8 % vs 52 %, test du log-rank, p < 0,01), les décès sont survenus de manière constante pendant toute la période de suivi dans le groupe STT, mais pas dans le groupe IM. L’incidence de l’insuffisance cardiaque a augmenté dans le groupe IM durant la période de suivi, mais pas dans le groupe STT (31,8 % vs 4 %, p < 0,01).
Le pronostic est plus sombre chez les patients qui ont subi un IM et un CC que chez ceux qui ont subi un STT et un CC, en raison du risque de survenue d’événements cardiovasculaires et de décès dans les 30 jours suivant l’événement de référence. Toutefois, les patients ayant subi un STT et un CS affichent aussi un taux de mortalité élevé, en particulier durant le suivi à long terme.]]></description><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/j.cjca.2019.10.012</identifier><identifier>PMID: 32249068</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Aged ; Arrhythmias, Cardiac - epidemiology ; Arrhythmias, Cardiac - etiology ; Arrhythmias, Cardiac - therapy ; Cardiopulmonary Resuscitation - methods ; Cardiopulmonary Resuscitation - statistics & numerical data ; Female ; Germany - epidemiology ; Heart Arrest - epidemiology ; Heart Arrest - etiology ; Heart Arrest - therapy ; Heart Failure - diagnosis ; Heart Failure - epidemiology ; Heart Failure - etiology ; Humans ; Incidence ; Long Term Adverse Effects - diagnosis ; Long Term Adverse Effects - epidemiology ; Long Term Adverse Effects - etiology ; Male ; Mortality ; Myocardial Infarction - complications ; Myocardial Infarction - diagnosis ; Myocardial Infarction - physiopathology ; Prognosis ; Shock, Cardiogenic - etiology ; Shock, Cardiogenic - mortality ; Shock, Cardiogenic - physiopathology ; Takotsubo Cardiomyopathy - complications ; Takotsubo Cardiomyopathy - diagnosis ; Takotsubo Cardiomyopathy - physiopathology</subject><ispartof>Canadian journal of cardiology, 2020-06, Vol.36 (6), p.860-867</ispartof><rights>2019 Canadian Cardiovascular Society</rights><rights>Copyright © 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c271t-5ad1d453138198f32112856a548eac215c9902120b99d43a7d2409412fe3789f3</citedby><cites>FETCH-LOGICAL-c271t-5ad1d453138198f32112856a548eac215c9902120b99d43a7d2409412fe3789f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0828282X19313467$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32249068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sattler, Katherine</creatorcontrib><creatorcontrib>El-Battrawy, Ibrahim</creatorcontrib><creatorcontrib>Gietzen, Thorsten</creatorcontrib><creatorcontrib>Kummer, Marvin</creatorcontrib><creatorcontrib>Lang, Siegfried</creatorcontrib><creatorcontrib>Zhou, Xiao-bo</creatorcontrib><creatorcontrib>Behnes, Michael</creatorcontrib><creatorcontrib>Borggrefe, Martin</creatorcontrib><creatorcontrib>Akin, Ibrahim</creatorcontrib><title>Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><description><![CDATA[Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) or of takotsubo syndrome (TTS). For both diseases, CS is related to a worse long-term outcome. The outcome of CS has not been studied in a direct comparison of patients with MI and patients with TTS.
Mortality and cardiovascular complications were compared in patients presenting with CS based on MI or TTS between 2003 and 2017 during a follow-up of 5 years. A total of 138 patients with TTS and 532 patients with MI were included. Of these, 66 patients with MI and 25 patients with TTS developed CS (12% vs 18%, P = 0.08).
Patients with MI and CS had more often malignant arrhythmias (74% vs 28%, P < 0.01), and need for resuscitation (80% vs 24%, P < 0.01) or death (71% vs 24%, P < 0.01) than patients with TTS and CS during the first 30 days. Although the overall rate of death remained higher in MI than in TTS (75.8% vs 52%, log rank, P < 0.01), deaths occurred in TTS constantly throughout the follow-up time, but not in MI. The incidence of heart failure increased in MI but not in TTS (31.8% vs 4%, P < 0.01) during follow-up.
Patients with MI and CS have a worse prognosis than patients with TTS and CS. This is driven by cardiovascular events or death during the first 30 days after the index event. However, patients with TTS and CS show high mortality as well, especially during long-term follow-up.
Le choc cardiogénique (CC) est une complication grave de l’infarctus du myocarde (IM) et du syndrome de Takotsubo (STT). Dans les deux cas, le CC est associé à une issue défavorable à long terme. L’issue du CC n’a jamais fait l’objet d’une comparaison directe entre patients ayant subi un IM et patients ayant subi un STT.
Les auteurs ont comparé la mortalité et les complications cardiovasculaires chez des patients ayant présenté un CC secondaire à un IM ou à un STT entre 2003 et 2017, au cours d’un suivi de 5 ans. Au total, 138 patients ayant subi un STT et 532 patients ayant subi un IM ont été inclus dans l’étude. Parmi eux, 66 patients ayant subi un IM et 25 patients ayant subi un STT ont présenté un CC (12 % vs 18 %, p = 0,08).
Au cours des 30 premiers jours, les patients ayant subi un IM et un CC ont plus souvent présenté des arythmies malignes (74 % vs 28 %, p < 0,01), nécessité une réanimation (80 % vs 24 %, p < 0,01) ou succombé (71 % vs 24 %, p < 0,01) que les patients ayant subi un STT et un CC. Bien que le taux de décès global soit demeuré plus élevé chez les patients ayant subi un IM que chez ceux ayant subi un STT (75,8 % vs 52 %, test du log-rank, p < 0,01), les décès sont survenus de manière constante pendant toute la période de suivi dans le groupe STT, mais pas dans le groupe IM. L’incidence de l’insuffisance cardiaque a augmenté dans le groupe IM durant la période de suivi, mais pas dans le groupe STT (31,8 % vs 4 %, p < 0,01).
Le pronostic est plus sombre chez les patients qui ont subi un IM et un CC que chez ceux qui ont subi un STT et un CC, en raison du risque de survenue d’événements cardiovasculaires et de décès dans les 30 jours suivant l’événement de référence. Toutefois, les patients ayant subi un STT et un CS affichent aussi un taux de mortalité élevé, en particulier durant le suivi à long terme.]]></description><subject>Aged</subject><subject>Arrhythmias, Cardiac - epidemiology</subject><subject>Arrhythmias, Cardiac - etiology</subject><subject>Arrhythmias, Cardiac - therapy</subject><subject>Cardiopulmonary Resuscitation - methods</subject><subject>Cardiopulmonary Resuscitation - statistics & numerical data</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Heart Arrest - epidemiology</subject><subject>Heart Arrest - etiology</subject><subject>Heart Arrest - therapy</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - etiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Long Term Adverse Effects - diagnosis</subject><subject>Long Term Adverse Effects - epidemiology</subject><subject>Long Term Adverse Effects - etiology</subject><subject>Male</subject><subject>Mortality</subject><subject>Myocardial Infarction - complications</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Prognosis</subject><subject>Shock, Cardiogenic - etiology</subject><subject>Shock, Cardiogenic - mortality</subject><subject>Shock, Cardiogenic - physiopathology</subject><subject>Takotsubo Cardiomyopathy - complications</subject><subject>Takotsubo Cardiomyopathy - diagnosis</subject><subject>Takotsubo Cardiomyopathy - physiopathology</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFOGzEQhi1UBCnwAj1UPvayqcf27tpSL1XUQiQQB4LgZjn2bHDIrlN7Fylvz65Ce-xppJnv_6X5CPkCbA4Mqu_buds6O-cM9LiYM-AnZAYaqqJmdfmJzJjiquCKP5-TzzlvGZNQ19UZORecS80qNSNh2e5TfENP74fexRZpbOjCJh_iBrvg6MNLdK90lcJmg2nE1ge6sq-xz8M60odD59MUWsR2b6fzU-hf6N0huqnC7uiya2xyfYjdJTlt7C7j1ce8II-_f60WN8Xt_fVy8fO2cLyGviitBy9LAUKBVo3gAFyVlS2lQus4lE5rxoGztdZeClt7LpmWwBsUtdKNuCDfjr3jX38GzL1pQ3a429kO45ANF6qSQtalGFF-RF2KOSdszD6F1qaDAWYmxWZrJsVmUjztRsVj6OtH_7Bu0f-L_HU6Aj-OAI5fvgVMJruAnUMfErre-Bj-1_8Ow7uMTg</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Sattler, Katherine</creator><creator>El-Battrawy, Ibrahim</creator><creator>Gietzen, Thorsten</creator><creator>Kummer, Marvin</creator><creator>Lang, Siegfried</creator><creator>Zhou, Xiao-bo</creator><creator>Behnes, Michael</creator><creator>Borggrefe, Martin</creator><creator>Akin, Ibrahim</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202006</creationdate><title>Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction</title><author>Sattler, Katherine ; El-Battrawy, Ibrahim ; Gietzen, Thorsten ; Kummer, Marvin ; Lang, Siegfried ; Zhou, Xiao-bo ; Behnes, Michael ; Borggrefe, Martin ; Akin, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-5ad1d453138198f32112856a548eac215c9902120b99d43a7d2409412fe3789f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Arrhythmias, Cardiac - epidemiology</topic><topic>Arrhythmias, Cardiac - etiology</topic><topic>Arrhythmias, Cardiac - therapy</topic><topic>Cardiopulmonary Resuscitation - methods</topic><topic>Cardiopulmonary Resuscitation - statistics & numerical data</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Heart Arrest - epidemiology</topic><topic>Heart Arrest - etiology</topic><topic>Heart Arrest - therapy</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - etiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Long Term Adverse Effects - diagnosis</topic><topic>Long Term Adverse Effects - epidemiology</topic><topic>Long Term Adverse Effects - etiology</topic><topic>Male</topic><topic>Mortality</topic><topic>Myocardial Infarction - complications</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Prognosis</topic><topic>Shock, Cardiogenic - etiology</topic><topic>Shock, Cardiogenic - mortality</topic><topic>Shock, Cardiogenic - physiopathology</topic><topic>Takotsubo Cardiomyopathy - complications</topic><topic>Takotsubo Cardiomyopathy - diagnosis</topic><topic>Takotsubo Cardiomyopathy - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sattler, Katherine</creatorcontrib><creatorcontrib>El-Battrawy, Ibrahim</creatorcontrib><creatorcontrib>Gietzen, Thorsten</creatorcontrib><creatorcontrib>Kummer, Marvin</creatorcontrib><creatorcontrib>Lang, Siegfried</creatorcontrib><creatorcontrib>Zhou, Xiao-bo</creatorcontrib><creatorcontrib>Behnes, Michael</creatorcontrib><creatorcontrib>Borggrefe, Martin</creatorcontrib><creatorcontrib>Akin, Ibrahim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sattler, Katherine</au><au>El-Battrawy, Ibrahim</au><au>Gietzen, Thorsten</au><au>Kummer, Marvin</au><au>Lang, Siegfried</au><au>Zhou, Xiao-bo</au><au>Behnes, Michael</au><au>Borggrefe, Martin</au><au>Akin, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>36</volume><issue>6</issue><spage>860</spage><epage>867</epage><pages>860-867</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><abstract><![CDATA[Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI) or of takotsubo syndrome (TTS). For both diseases, CS is related to a worse long-term outcome. The outcome of CS has not been studied in a direct comparison of patients with MI and patients with TTS.
Mortality and cardiovascular complications were compared in patients presenting with CS based on MI or TTS between 2003 and 2017 during a follow-up of 5 years. A total of 138 patients with TTS and 532 patients with MI were included. Of these, 66 patients with MI and 25 patients with TTS developed CS (12% vs 18%, P = 0.08).
Patients with MI and CS had more often malignant arrhythmias (74% vs 28%, P < 0.01), and need for resuscitation (80% vs 24%, P < 0.01) or death (71% vs 24%, P < 0.01) than patients with TTS and CS during the first 30 days. Although the overall rate of death remained higher in MI than in TTS (75.8% vs 52%, log rank, P < 0.01), deaths occurred in TTS constantly throughout the follow-up time, but not in MI. The incidence of heart failure increased in MI but not in TTS (31.8% vs 4%, P < 0.01) during follow-up.
Patients with MI and CS have a worse prognosis than patients with TTS and CS. This is driven by cardiovascular events or death during the first 30 days after the index event. However, patients with TTS and CS show high mortality as well, especially during long-term follow-up.
Le choc cardiogénique (CC) est une complication grave de l’infarctus du myocarde (IM) et du syndrome de Takotsubo (STT). Dans les deux cas, le CC est associé à une issue défavorable à long terme. L’issue du CC n’a jamais fait l’objet d’une comparaison directe entre patients ayant subi un IM et patients ayant subi un STT.
Les auteurs ont comparé la mortalité et les complications cardiovasculaires chez des patients ayant présenté un CC secondaire à un IM ou à un STT entre 2003 et 2017, au cours d’un suivi de 5 ans. Au total, 138 patients ayant subi un STT et 532 patients ayant subi un IM ont été inclus dans l’étude. Parmi eux, 66 patients ayant subi un IM et 25 patients ayant subi un STT ont présenté un CC (12 % vs 18 %, p = 0,08).
Au cours des 30 premiers jours, les patients ayant subi un IM et un CC ont plus souvent présenté des arythmies malignes (74 % vs 28 %, p < 0,01), nécessité une réanimation (80 % vs 24 %, p < 0,01) ou succombé (71 % vs 24 %, p < 0,01) que les patients ayant subi un STT et un CC. Bien que le taux de décès global soit demeuré plus élevé chez les patients ayant subi un IM que chez ceux ayant subi un STT (75,8 % vs 52 %, test du log-rank, p < 0,01), les décès sont survenus de manière constante pendant toute la période de suivi dans le groupe STT, mais pas dans le groupe IM. L’incidence de l’insuffisance cardiaque a augmenté dans le groupe IM durant la période de suivi, mais pas dans le groupe STT (31,8 % vs 4 %, p < 0,01).
Le pronostic est plus sombre chez les patients qui ont subi un IM et un CC que chez ceux qui ont subi un STT et un CC, en raison du risque de survenue d’événements cardiovasculaires et de décès dans les 30 jours suivant l’événement de référence. Toutefois, les patients ayant subi un STT et un CS affichent aussi un taux de mortalité élevé, en particulier durant le suivi à long terme.]]></abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>32249068</pmid><doi>10.1016/j.cjca.2019.10.012</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0828-282X |
| ispartof | Canadian journal of cardiology, 2020-06, Vol.36 (6), p.860-867 |
| issn | 0828-282X 1916-7075 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2386434753 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Arrhythmias, Cardiac - epidemiology Arrhythmias, Cardiac - etiology Arrhythmias, Cardiac - therapy Cardiopulmonary Resuscitation - methods Cardiopulmonary Resuscitation - statistics & numerical data Female Germany - epidemiology Heart Arrest - epidemiology Heart Arrest - etiology Heart Arrest - therapy Heart Failure - diagnosis Heart Failure - epidemiology Heart Failure - etiology Humans Incidence Long Term Adverse Effects - diagnosis Long Term Adverse Effects - epidemiology Long Term Adverse Effects - etiology Male Mortality Myocardial Infarction - complications Myocardial Infarction - diagnosis Myocardial Infarction - physiopathology Prognosis Shock, Cardiogenic - etiology Shock, Cardiogenic - mortality Shock, Cardiogenic - physiopathology Takotsubo Cardiomyopathy - complications Takotsubo Cardiomyopathy - diagnosis Takotsubo Cardiomyopathy - physiopathology |
| title | Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A26%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20Outcome%20of%20Cardiogenic%20Shock%20Triggered%20by%20Takotsubo%20Syndrome%20Compared%20With%20Myocardial%20Infarction&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Sattler,%20Katherine&rft.date=2020-06&rft.volume=36&rft.issue=6&rft.spage=860&rft.epage=867&rft.pages=860-867&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/j.cjca.2019.10.012&rft_dat=%3Cproquest_cross%3E2386434753%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2386434753&rft_id=info:pmid/32249068&rft_els_id=S0828282X19313467&rfr_iscdi=true |